Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Respiratory Tract 24. September 2026
Search
medline.ch
Respiratory Tract
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8112  Previews Next
   
   Articles 1 - 20 / 162239  
   
Second-Line Therapy Following Osimertinib in Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer at an Academic Medical Center.
Cancer Rep (Hoboken)
Rafizadeh M, Bogdan S, Lee J, Garcia C, Saxena A, Zhou K, Parang B.
PMID: 42778155 [PubMed - indexed for MEDLINE]


Sphingolipids as central regulators of therapy resistance and immunity in lung cancer.
Biochimie
Paque M, Aliju A, Blomme A.
PMID: 42778085 [PubMed - as supplied by publisher]


Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.
Crit Rev Oncol Hematol
Arrieta O, Caballé-Pérez E, Cabrera-Miranda L, Cardona AF, Davila-Dupont D, Velasco-Córdoba M, Treviño LAC.
PMID: 42778080 [PubMed - as supplied by publisher]


Recent Advances and Future Challenges of Bispecific Antibodies in Lung Cancer.
Crit Rev Oncol Hematol
Du M, Han Y, Jin R, Li H.
PMID: 42778079 [PubMed - as supplied by publisher]


Therapeutic applications of metal complexes in lung cancer treatment.
Eur J Med Chem
Feng J, Li H, Cai CY, Mo L, Zhu Y, Lei ZN, Lai Y, Zhou B, Pan Y, Zeng L, Li J.
PMID: 42777670 [PubMed - as supplied by publisher]


Psychological and psychosocial interventions in patients with lung cancer: A meta-analysis of randomised controlled trials and trial sequential analysis.
Eur J Surg Oncol
Aini N, Janitra FE, Lin CL, Fauk NK, Efendi F, Arifin H.
PMID: 42777643 [PubMed - as supplied by publisher]


Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial.
Lung Cancer
Ledda RE, Sabia F, Beck KS, Milanese G, Ruggirello M, Balbi M, Rolli L, Boeri M, Sozzi G, Sverzellati N, Marchianò AV, Pastorino U.
PMID: 42777510 [PubMed - as supplied by publisher]


Robotic-assisted bronchoscopic biopsy and EBUS-TBNA in lung cancer: An outcome comparison between clinical and pathological staging.
Lung Cancer
Fernandez-Bussy S, Murillo-Torres RM, Rojas-Zapata TA, Yu Lee-Mateus A, Gutierrez-Gallegos P, Abia-Trujillo D, Vu LH, Chadha RM, Robertson KS, Husta BC.
PMID: 42777509 [PubMed - as supplied by publisher]


Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study.
Lung Cancer
De Gunten A, Mogenet A, Bronstein A, Pollien E, Le Floch H, Pluvy J, Paleiron N, Tomasini P, Greillier L, Bylicki O.
PMID: 42777508 [PubMed - as supplied by publisher]


Exploring Primary Care Interventions to Increase Lung, Breast, and Cervical Cancer Screening With Individuals Experiencing Marginalization: A Scoping Review.
Cancer Control
Jantzen E, Quiambao JA, LeBlanc D, Cernat A, Calleja S, Tinmouth J, Lofters AK, Ruco A.
PMID: 42777132 [PubMed - indexed for MEDLINE]


Sensitivity for Malignancy with Navigation Bronchoscopy in Small Lung Nodules.
Adv Respir Med
Näslund A, Ottosson M, Karadzovska-Kotevska M, Teurneau-Hermansson K, Kosieradzki J, Barath S, Akbarshahi H.
PMID: 42776701 [PubMed - indexed for MEDLINE]


Informing the cultural adaptation of a lung cancer screening shared decision-making and navigation intervention for Hispanic adults: a qualitative study.
Cancer Causes Control
Arana-Chicas E, Reyes AV, Chavez-Iniguez A, Macenat M, Ferrante J, Capurro C, Kinney AY.
PMID: 42776309 [PubMed - indexed for MEDLINE]


Real-world use of G-CSF primary prophylaxis in small cell lung cancer: secondary data analysis from the French national cohorts KBP-2020-CPHG and ESCAP-2020-CPHG.
Support Care Cancer
Falchero L, Scotté F, Couraud S, Menia K, Debieuvre D.
PMID: 42776256 [PubMed - indexed for MEDLINE]


FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.
Acta Oncol
Knuuttila A, Ekblom MH, Nurmi LO, Bonin A, Heikkilä EK, Silvoniemi M.
PMID: 42776017 [PubMed - indexed for MEDLINE]


Comparative evaluation of VoxelMorpand conventional deformable image registration algorithms for thoracic 4D-CT in radiotherapy.
J Appl Clin Med Phys
Sakai M, Nakao M, Hirashima H, Yoneyama M, Kishi N, Mizowaki T, Nakamura M.
PMID: 42775600 [PubMed - indexed for MEDLINE]


Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume.
J Appl Clin Med Phys
Wang Y, Xu D, Liu Y, Zhang X, Yu L.
PMID: 42775580 [PubMed - indexed for MEDLINE]


Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review.
Cureus
Kumar S, Mudgal SK, Varikasuvu SR, Singh D, Singh H, Mahato S, Sarangi PK, Mondal H.
PMID: 42775053 [PubMed]


Correction: Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.
Front Med (Lausanne)
Frontiers Production Office.
PMID: 42775016 [PubMed]


Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.
EClinicalMedicine
Hulskotte LMG, Veerman GDM, Lanser DAC, Reyners AKL, van Schaik RHN, Dingemans AC, Taxis K, Mathijssen RHJ, Jansman FGA.
PMID: 42775005 [PubMed]


Respiratory omics for early detection of COPD-to-lung cancer transition: mechanisms, biomarkers and clinical translation.
Front Cell Dev Biol
Liu C, Jia W, Jing S, Dong C.
PMID: 42774579 [PubMed]


   
   Articles 1 - 20 / 162239    Page 1 of 8112  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1